9
we analyze the yeast and mold species present in 10 real world, dispensary-derived 50
Cannabis samples by quantitative PCR and sequencing, and demonstrate the presence of 51 several mycotoxin producing fungal strains that are not detected by widely used culture-52 based assays. 53 54
Results 55
A commercially available Total Yeast and Mold qPCR assay (TYM-PathogINDICAtor, 56
Medicinal Genomics, Woburn) was used to screen for fungal DNA in a background of 57
host Cannabis DNA. The TYM qPCR assay targets the 18S rDNA ITS (Internal 58
Transcribed Spacer) region using modified primers described previously 19, 20 . Fungal 59
DNA amplified using these primers may also be subjected to next generation sequencing 60
to identify the contributing yeast and mold species. ITS sequencing has been widely used 61
to identify and enumerate fungal species present in a given sample 21 . 62 63
We purified DNA from Cannabis samples obtained from two different geographic 64
regions (Amsterdam and Massachusetts) several years apart (2011 and 2015) . The 65 majority of samples purified and screened with ITS qPCR were negative for 66 amplification signal implying reagents clean of fungal contamination. Six of the 17 67
dispensary-derived Cannabis samples tested positive for yeast and mold in the TYM 68 qPCR assay. These results were compared with the results derived from three 69 commercially available culture based detection systems for each of the 17 samples (3M 70
Petrifilm TM 3M Microbiology, St. Paul, MN, USA, SimPlates TM Biocontrol Systems, 71
Bellevue,WA, USA, BioLumix TM Neogen, Lansing MI, USA). Of the 6 qPCR positive 72 samples, two tested negative in all 3 culture-based assays and four tested negative in 1 or 73 2 of the culture-based assays ( Table. 1). None of the qPCR negative samples tested 74 positive in any of the culture based assays. Each of the 6 discordant samples was 75 subjected to ITS sequencing to precisely identify the collection of microbes present. Four 76 additional samples from a different geographic origin (Amsterdam) were also subjected 77 to ITS sequencing, for a total of 10 Cannabis samples.
79
Each discordant sample presented with an array of microbial species, as shown in figure  80 2. No sample presented with a single dominant species, and each sample displayed 81 multiple species of interest. Of particular concern were the identified DNA sequences 82 from toxin producing species: Aspergillus versicolor 22-26 , Aspergillus terreus 27 , 83
Penicillium citrinum 28-30 , Penicillium paxilli 31, 32 . 84 85
We further analyzed the ITS sequence alignments using the whole genome shotgun based 86 microbiome classification software known as One Codex 33 . Nine of the ten samples 87 sequenced showed the presence of P. paxilli (Figure 3 ). To verify the accuracy of this 88 ITS phylotyping, a gene involved in the Paxilline toxin Biosynthesis pathway of P. 89
paxilli was amplified with PaxPss1 and PaxPss2 primers described by Saikia et al 34 Paxilline is a tremorgenic and ataxic potassium channel blocker and has been shown to 129 attenuate the anti-seizure properties of cannabidiol in certain mouse models [42] [43] [44] . Paxilline 130 is reported to have tremorgenic effects at nanomolar concentrations and is responsible for 131
Ryegrass-staggers disease 45 . Cannabidiol is often used at micromolar concentrations for 132 seizure reduction implying sub-percentage contamination of Paxilline could still be a 133
concern. Citrinin is a mycotoxin that disrupts Ca2+ efflux in the mitochondrial 134 permeability transition pore (mPTP) 46-53 . Ryan et al. demonstrated that cannabidiol 135 affects this pathway suggesting a potential concern for CBD-mycotoxin interaction 54 . 136
Considering the hydrophobicity of Paxilline and the recent interest in the use of 137 cannabidiol derived from cannabis flower oils for drug resistant Epilepsy, more precise 138 molecular screening of fungal toxins may be warranted 55-60 . 139 140
Our survey of cannabis flowers in this study was limited. Further screening will be 141 required to define a set of tests that can adequately capture all risks. While ELISA assays 142 are easy point of use tests that can be used to detect fungal toxins, they can suffer from 143 lack of sensitivity and cross reactivity. ITS amplification and sequencing offers 144
hypothesis-free testing that can complement the lack of specificity in ELISA assays. 145
Appropriate primer design can survey a broad spectrum of microbial genomes while 146 affording rapid iteration of design. Quantitative PCR has also demonstrated single 147 molecule sensitivity and linear dynamic range over 5 orders of magnitude offering a very 148 robust approach for detection of microbial risks. This may be important for the detection 149 of nanomolar potency mycotoxins. Further studies are required to validate better 150 detection methods for these toxins and verify whether Paxilline or Citrinin are present on 151 cannabis at concentrations that present a clinical risk. 152 153
Conclusions 154
These results demonstrate that culture based techniques superimposed from the food 155 industry should be re-evaluated based on the known microbiome of actual Cannabis 156 flowers in circulation at dispensaries. Several mycotoxin producing molds were detected 157 that can potentially interfere with the medical use of cannabidiol. These microbes failed 158
to grow on traditional culture based platforms but were rapidly detected with molecular 159 based techniques. Further studies are required to quantitate the presence and 160
concentration of mycotoxin production. Figure 1B . Sample KD8 fails to culture any Total Yeast and mold yet demonstrates significant TYM qPCR signal. Sample was graduated to ITS based next generation sequencing. Figure 1C . Sample Liberty Haze was tested with 3 culture based methods and compared to qPCR. Sample was graduated to ITS based next generation sequencing. Figure 2 --DNA sequencing of ITS3 amplicons from culture negative samples that are qPCR positive for Total Yeast and Mold tests. Penicillium and Aspergillus are commonly found (Y axis) but at different read counts in each sample (X axis). Read counts are more a reflection of sample normalization for sequencing than inter sample quantitation provided by qPCR. Figure 3 --One Codex classification of ITS reads. P.Paxilli is the most frequently found contaminant in Cannabis flowers. P.Citrinum is not in the One Codex database at this time. One Codex utilizes a fast k--mer based approach for whole genome shotgun classification and can be influenced by read trimming and database content. The reads provided to MG--RAST were trimmed and FLASH'd (Paired end reads merged when overlapping) prior to classification. K--mer based approaches can significantly differ from longer word size methods and this underscores the importance of confirmatory PCR in microbiome analysis. Figure 4 . PaxP PCR demonstrates amplification of a 725bp band in sample KD8(A). PCR products were made into a shotgun library with Nextera and sequenced on an Illumina MiSeq with 2x75bp reads to over 10,000X coverage. Reads were mapped with CLCbio 4 to NCBI Accession number HM171111.1. Paired reads are displayed as blue lines, Green and Red lines are unpaired reads. Read Coverage over the amplicon is depicted in a blue histogram over the cluster while paired end read distance is measured in a red histogram over the region. Off target read mapping is limited (B). Alignment of PCR primers to P.Paxilli reference shows a 5 prime mismatch that is a result of the primers being designed to target spliced RNA according to Saikia et al.
